Home
All Journals
Journal of Dermatological Treatment
List of Issues
Volume 34, Issue 1
Drug tolerability versus drug safety

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Journal of Dermatological Treatment Volume 34, 2023 - Issue 1

Submit an article Journal homepage

Open access

2,659

Views

CrossRef citations to date

Altmetric

Editorial

Drug tolerability versus drug safety

Stuti Prajapatia Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, USACorrespondence[email protected]

https://orcid.org/0009-0006-9889-5325 View further author information

Rachel Taoa Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, USAView further author information

Steven R. Feldmana Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA;b Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC, USA;c Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA;d Department of Social Sciences & Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USAView further author information

Article: 2202786 | Received 09 Apr 2023, Accepted 10 Apr 2023, Published online: 27 Apr 2023

Cite this article
https://doi.org/10.1080/09546634.2023.2202786
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Services USDoHaH, Administration FaD. Guidance for Industry E9 statistical principles for clinical trials; 1998. Available from: https://www.fda.gov/media/71336/download.
Google Scholar
Stanulović V, Hodolic M, Mitsikostas DD, et al. Drug tolerability: how much ambiguity can be tolerated? A systematic review of the assessment of tolerability in clinical studies. Br J Clin Pharmacol. 2022;88(2):1–2.
Web of Science ®Google Scholar
Crowley J, Thaçi D, Joly P, et al. Long-term safety and tolerability of apremilast in patients with psoriasis: pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2). J Am Acad Dermatol. 2017;77(2):310–317.e1.
PubMed Web of Science ®Google Scholar
Administration USFD. Step 3: clinical research; 2018. Available from: https://www.fda.gov/patients/drugdevelopment-process/step-3-clinical-research.
Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references